KRAS and colorectal carcinoma: CRC MSI-High cell lines bearing opposite genotypes of p53 and KRAS, where one gene is WT and the other mutant (e.g., LS411N, HCT 116) showed the highest sensitivity and the most significant reduction in cell proliferation (52% and 89%, respectively).